Navigation Links
Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
Date:5/8/2008

PALO ALTO, Calif., May 8 /PRNewswire/ -- Anacor Pharmaceuticals announced today that it will present six posters on topical anti-inflammatory candidates, AN2728 and AN2898, at the upcoming International Investigative Dermatology 2008 Conference, taking place May 14-17, 2008 in Kyoto, Japan. The IID Conference is the Fifth Joint Meeting of the European Society for Dermatological Research (ESDR), the Japanese Society for Investigative Dermatology (JSID) and the Society for Investigative Dermatology (SID).

Poster Presentations:

Poster Session 1: Friday May 16, 5:30-7 p.m.

Poster title (#89): In vitro activity and mechanism of action of AN2728,

a novel oxaborole in development for treatment of psoriasis

Poster title (#367): AN2728, a novel oxaborole in development for

treatment of psoriasis, demonstrates significant activity in a micro

plaque study

Poster Session 2: Saturday May 17, 1:15-2:45 p.m.

Poster title (#84): Preclinical toxicology of AN2728, a novel oxaborole

in development for the topical treatment of psoriasis

Poster title (#86): AN2898, a novel oxaborale compound with

anti-inflammatory activity: mechanism of action and in vitro cytokine

inhibition

Poster title (#88): Structure-activity studies of AN2728 and AN2898,

novel oxaborole compounds with anti-inflammatory activities

Poster title (#90): AN2898, a novel oxaborale compound with

anti-inflammatory activity: results of in vivo efficacy and preclinical

safety studies

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing topical applications of its compounds to treat fungal, bacterial and inflammatory diseases. Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for th
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anacor Files Registration Statement for Initial Public Offering
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... steps for its Oral Amphotericin B program.  The ... in vitro work involving samples from HIV/AIDS ... to complete pre clinical studies and regulatory filings ... clinical trial, utilizing approximately $700,000 of funding and ...
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
(Date:10/20/2014)... Convey Computer , the leader in hybrid-core ... University won first place in the 2014 MemoCODE ... team’s solution achieved the highest overall performance in the ... finisher. , Experts from all segments of the commercial ... using a variety of design tools, hardware and software. ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... REHOVOT, Israel and JERSEY CITY, New Jersey, July 3, ... of microRNA-based diagnostics and therapeutics, announced today,it will present ... at 8:30 am EST at the Mandarin Oriental Hotel ... (Nasdaq: ROSG ) is a leader in the ...
... company to offer choice of two distinct drugs on ... separate drug-eluting stent platforms, ... ) today announced that the U.S. Food and Drug,Administration (FDA) ... of coronary artery disease. The,PROMUS Stent is a private-labeled XIENCE(TM) ...
... Bioniche,s growing line of injectable ... ... and manufacturer of injectable pharmaceuticals, announced today,the acquisition of Baxter Healthcare Corporation,s ... mg/mL, 15 mL vial -- ENLON-PLUS(R) (edrophonium chloride, USP and atropine ...
Cached Biology Technology:Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2
(Date:10/17/2014)... critical and pertinent for practicing physicians and clinicians given ... The Journal, Disaster Medicine and Public Health Preparedness ... Public Health, to surround the public, medical professionals and ... , On October 17, the journal published ... was prepared by Dr. Eric Toner, internist and emergency ...
(Date:10/16/2014)... Mary,s Virginia Institute of Marine Science have received ... Agency to identify the streams and wetlands most ... to help local governments and citizens conserve these ... a dataset of tidal-marsh observations first gathered by ... historical baseline can today,s researchers accurately map the ...
(Date:10/16/2014)... women experienced improvements in vaginal atrophy, with no ... after 12 weeks of daily 10 milligram (mg) ... supplement previously shown to help relieve certain menopause ... reported in a poster at the North American ... "These data documented improved vaginal epithelium, without significant ...
Breaking Biology News(10 mins):EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
... us, deep within Earth,s crust, life is astir. Organisms ... thinking of life. Instead, thriving there are microbes, the ... the biological diversity of these deep biosphere microorganisms may ... about them is still unknown, including the origin of ...
... at the Hebrew University of Jerusalem has found a way to ... those that don,t have one. Smell plays an important role ... fruit and vegetables, perfume, and even a partner. And yet, smell ... what we taste, explains Prof. Alexander Vainstein, who is heading the ...
... SPRING HARBOR, N.Y. (Oct. 7, 2008) ... and analysis has just been released by Cold ... day-to-day use in the laboratory, it includes essential ... experimental strategies, and troubleshooting advice on the most ...
Cached Biology News:Deep biosphere research points to new methods for recovering petroleum 2Deep biosphere research points to new methods for recovering petroleum 3Deep biosphere research points to new methods for recovering petroleum 4Deep biosphere research points to new methods for recovering petroleum 5Scent on demand: Hebrew University scientists enhance the scent of flowers 2New lab manual focuses on essential methods for purifying and characterizing proteins 2
APO-BrdU™ TUNEL Assay Kit *with Alexa Fluor® 488 anti-BrdU* *60 assays*...
...
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: